CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.950
-0.070 (-1.74%)
Mar 5, 2026, 10:20 AM EST - Market open

CervoMed Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
9.4497.794.0937.3118.52
Short-Term Investments
17.8629.92----
Cash & Short-Term Investments
27.2938.927.794.0937.3118.52
Cash Growth
-41.50%399.46%90.37%-89.03%101.53%30.60%
Other Receivables
1.362.250.92---
Total Trade Receivables
1.362.250.92---
Other Current Assets
1.961.911.260.060.510.26
Total Current Assets
30.6143.089.964.1637.8218.78
Net Property, Plant & Equipment
-----0.3
Other Intangible Assets
-----8.64
Other Long-Term Assets
--0.01-0.020.02
Total Assets
30.6143.089.974.1637.8427.73
Accounts Payable
1.351.510.660.10.950.55
Accrued Expenses
3.252.371.930.641.981.78
Short-Term Debt
---12.41--
Current Portion of Leases
-----0.11
Total Current Liabilities
4.63.882.613.162.932.44
Long-Term Leases
-----0.04
Other Long-Term Liabilities
-----0.44
Total Long-Term Liabilities
-----0.48
Total Liabilities
4.63.882.613.162.932.92
Preferred Stock
---48.57--
Common Stock
0.010.010.01000.06
Additional Paid-in Capital
115.61109.8761.8118.98164.91130.66
Accumulated Other Comprehensive Income
0.010.06----
Retained Earnings
-89.61-70.73-54.44-52.27-130.01-105.91
Shareholders' Equity
26.0139.27.38-33.2934.9124.81
Total Liabilities & Equity
30.6143.089.974.1637.8427.73
Total Debt
-0012.4100.15
Net Cash (Debt)
27.2938.927.79-8.3237.3118.37
Net Cash Growth
-29.88%399.46%--103.16%31.85%
Net Cash Per Share
3.044.822.93-16.0628.7525.59
Book Value
26.0139.27.38-33.2934.9124.81
Book Value Per Share
2.904.862.77-64.2426.9034.57
Tangible Book Value
26.0139.27.38-33.2934.9116.18
Tangible Book Value Per Share
2.904.862.77-64.2426.9022.54
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q